Boyu Capital

Boyu Capital

Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China.

Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China. The firm was founded by Mary Ma in 2010, in Beijing, Beijing, China.

The firm is interested in Late Stage ventures and private equity investments. The firm is headquartered out of Hong Kong as well as Beijing. The firm is interested in companies such as Kuaishou Technology, Chengjia Apartment, Waterdrop, Yimidida, Antengene Corporation, NetEase Cloud Music, LianLian Pay, KLOOK, Curon Biopharma, and MEGVII. The firm looks to be a lead investor during investments.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
LifeMine Therapeutics

A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.

Face++ is a company developing and operating a face detection, recognition, and analysis platform for websites, mobile applications and smart televisions.

NetEase Cloud Music is a company with an online music platform and offers streaming services. It was founded in 2013 and is located in Beijing, China.

Antengene is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines.

Kuaishou provides a photo and video-sharing application.

A company offering a medical insurance platform.

Brii Biosciences is a Durham, North Carolina-based company.

Viela Bio is a Gaithersburg, Maryland-based company.

10 Results
Results per page:
Page 1 of 1

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Boyu Capital Fund I, L.P.
239,625,000
June 24, 2011
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Antengene Corporation Limited
November 20, 2020
www.prnewswire.com:443
/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer...
November 17, 2020
BioSpace
D3 Bio Launches with US$200 Million Investment to Develop Precision Medicines Addressing Unmet Patient Needs in Oncology & Immunology - read this article along with other careers information, tips and advice on BioSpace

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.